Загрузка...
Predictive value of the SLC22A18 protein expression in glioblastoma patients receiving temozolomide therapy
BACKGROUND: Our previous study showed that SLC22A18 downregulation and promoter methylation were associated with the development and progression of glioma and the elevated expression of SLC22A18 was found to increase the sensitivity of glioma U251 cells to the anticancer drug 1,3-bis(2-chloroethyl)-...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3610152/ https://ncbi.nlm.nih.gov/pubmed/23514245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-11-69 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|